An experimental model for the study of well-differentiated and dedifferentiated liposarcoma; deregulation of targetable tyrosine kinase receptors

Pharmacologic Inhibition of Cyclin-Dependent Kinases 4 and 6 Arrests the Growth of Glioblastoma Multiforme Intracranial Xenografts

(2010) K. Michaud et al.   CANCER RESEARCH

Diallyl Trisulfide Inhibits Phorbol Ester-Induced Tumor Promotion, Activation of AP-1, and Expression of COX-2 in Mouse Skin by Blocking JNK and Akt Signaling

(2010) S. Shrotriya et al.   CANCER RESEARCH

Vimentin Is a Novel Anti-Cancer Therapeutic Target; Insights from In Vitro and In Vivo Mice Xenograft Studies

(2010) Guy Lahat et al.   PLoS One

Clinical and Biological Significance of CDK4 Amplification in Well-Differentiated and Dedifferentiated Liposarcomas

(2009) A. Italiano et al.   CLINICAL CANCER RESEARCH

Selective elimination of amplifiedCDK4sequences correlates with spontaneous adipocytic differentiation in liposarcoma

(2009) Zofia Hélias-Rodzewicz et al.   GENES CHROMOSOMES & CANCER

Can MDM2 and CDK4 make the diagnosis of well differentiated/dedifferentiated liposarcoma? An immunohistochemical study on 129 soft tissue tumours

(2009) P B Aleixo et al.   JOURNAL OF CLINICAL PATHOLOGY

c‐Junamplification and overexpression are oncogenic in liposarcoma but not always sufficient to inhibit the adipocytic differentiation programme

(2009) Eric L Snyder et al.   JOURNAL OF PATHOLOGY

Similarity in genetic alterations between paired well-differentiated and dedifferentiated components of dedifferentiated liposarcoma

(2009) Andrew E Horvai et al.   MODERN PATHOLOGY

Other Targetable Sarcomas

(2009) Veridiana Pires de Camargo et al.   SEMINARS IN ONCOLOGY

Well-differentiated and dedifferentiated liposarcomas

(2009) Jean-Michel Coindre et al.   VIRCHOWS ARCHIV

A Developmental Model of Sarcomagenesis Defines a Differentiation-Based Classification for Liposarcomas

(2008) Igor Matushansky et al.   AMERICAN JOURNAL OF PATHOLOGY

Resectable Well-Differentiated versus Dedifferentiated Liposarcomas: Two Different Diseases Possibly Requiring Different Treatment Approaches

(2008) G. Lahat et al.   ANNALS OF SURGICAL ONCOLOGY

Heparin-binding epidermal growth factor-like growth factor inhibits adipocyte differentiation at commitment and early induction stages

(2008) Jeong Soon Lee et al.   DIFFERENTIATION

HMGA2 is the partner of MDM2 in well-differentiated and dedifferentiated liposarcomas whereas CDK4 belongs to a distinct inconsistent amplicon

(2008) Antoine Italiano et al.   INTERNATIONAL JOURNAL OF CANCER

Diagnosis and management of lipomatous tumors

(2008) Kimberly Moore Dalal et al.   JOURNAL OF SURGICAL ONCOLOGY

Fluorescence in situ hybridization for MDM2 gene amplification as a diagnostic tool in lipomatous neoplasms

(2008) Joshua Weaver et al.   MODERN PATHOLOGY

Oncocytic renal cell carcinoma with immunohistochemical properties of renal oncocytoma

(2008) Kien T. Mai et al.   PATHOLOGY RESEARCH AND PRACTICE